Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||||
| Revenue [abstract] | ||||||||||||||||
| Revenue | — | — |
200,450,000
EUR
|
— | — | — | — | — | — | — |
193,148,000
EUR
|
— | — | — | — | — |
| Material income and expense [abstract] | ||||||||||||||||
| Finance income (cost) | — | — |
929,000
EUR
|
— | — | — | — | — | — | — |
256,000
EUR
|
— | — | — | — | — |
| Miscellaneous other operating expense | — | — |
1,672,000
EUR
|
— | — | — | — | — | — | — |
1,506,000
EUR
|
— | — | — | — | — |
| Revenue and other operating income | — | — |
207,123,000
EUR
|
— | — | — | — | — | — | — |
199,618,000
EUR
|
— | — | — | — | — |
| Operating expense | — | — |
201,126,000
EUR
|
— | — | — | — | — | — | — |
192,407,000
EUR
|
— | — | — | — | — |
| Expenses by nature [abstract] | ||||||||||||||||
| Raw materials and consumables used | — | — |
23,149,000
EUR
|
— | — | — | — | — | — | — |
25,101,000
EUR
|
— | — | — | — | — |
| Cost of merchandise sold | — | — |
120,026,000
EUR
|
— | — | — | — | — | — | — |
115,102,000
EUR
|
— | — | — | — | — |
| Services expense | — | — |
7,970,000
EUR
|
— | — | — | — | — | — | — |
6,655,000
EUR
|
— | — | — | — | — |
| Classes of employee benefits expense [abstract] | ||||||||||||||||
| Short-term employee benefits expense [abstract] | ||||||||||||||||
| Short-term employee benefits expense | — | — |
33,345,000
EUR
|
— | — | — | — | — | — | — |
28,889,000
EUR
|
— | — | — | — | — |
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||||
| Depreciation and amortisation expense [abstract] | ||||||||||||||||
| Depreciation and amortisation expense | — | — |
7,254,000
EUR
|
— | — | — | — | — | — | — |
7,707,000
EUR
|
— | — | — | — | — |
| Impairment loss (reversal of impairment loss) recognised in profit or loss | — | — |
154,000
EUR
|
— | — | — | — | — | — | — |
191,000
EUR
|
— | — | — | — | — |
| Other expenses, by nature | — | — |
7,600,000
EUR
|
— | — | — | — | — | — | — |
7,056,000
EUR
|
— | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||||||||||||||||
| Disclosure of attribution of expenses by nature to their function [line items] | ||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||||
| Share of profit (loss) of associates accounted for using equity method | — | — |
1,287,000
EUR
|
— | — | — | — | — | — | — |
1,336,000
EUR
|
— | — | — | — | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||||
| Comprehensive income |
42,000
EUR
|
-
EUR
|
6, 927
EUR
|
-
EUR
|
114,000
EUR
|
121,000
EUR
|
6,878,000
EUR
|
6,885,000
EUR
|
-
EUR
|
-
EUR
|
7,368,000
EUR
|
7,000
EUR
|
7,248,000
EUR
|
-
EUR
|
7,361,000
EUR
|
113,000
EUR
|
| Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract] | ||||||||||||||||
| Comprehensive income, attributable to owners of parent | — | — |
6,885,000
EUR
|
— | — | — | — | — | — | — |
7,361,000
EUR
|
— | — | — | — | — |
| Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract] | ||||||||||||||||
| Comprehensive income, attributable to non-controlling interests | — | — |
42,000
EUR
|
— | — | — | — | — | — | — |
7,000
EUR
|
— | — | — | — | — |